Xencor
XNCR
63 hedge funds and large institutions have $226M invested in Xencor in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 2 closing their positions.
700% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 2
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
81% more capital invested
Capital invested by funds: $125M → $226M (+$101M)
56% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 16
24% more funds holding
Funds holding: 51 → 63 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$2.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.8M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$1.75M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$1.75M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$989K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$2.7M |
| 2 |
FCMI
Foresite Capital Management I
Larkspur,
California
|
-$2.6M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.59M |
| 4 |
QF
QVT Financial
New York
|
-$1.26M |
| 5 |
Primecap Management
Pasadena,
California
|
-$767K |
XNCR Hedge Fund Activity: Q4 2014 in Review
63 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Xencor (XNCR) for Q4 2014, worth a combined $226M — up 81% from $125M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new XNCR positions and 2 closed out — a net gain of 14 holders — while 25 added to existing stakes and 16 trimmed.
The largest buyer was OrbiMed, adding an estimated $2.4M. The largest seller was Broadfin Capital, cutting an estimated $2.7M.
- 63 institutional investors held Xencor (XNCR) as of Q4 2014, up from 51 in Q3 2014.
- Funds reported $226M of Xencor stock for Q4 2014, up 81% quarter-over-quarter.
- 16 funds opened new Xencor positions in Q4 2014 and 2 closed out, a net change of +14 holders.
- The largest Xencor buyer in Q4 2014 was OrbiMed, an estimated $2.4M added.
- The largest Xencor seller in Q4 2014 was Broadfin Capital, an estimated $2.7M sold.
Based on aggregated 13F filings for Q4 2014.